All SightGlass Vision Diffusion Optics Technology (DOT) Articles
-
2.6KEditor’s PerspectiveInnovative Myopia Control Spectacle Lenses on the Horizon
June 1, 2022 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE There is good reason to slow the progression of juvenile-onset myopia....
-
7.6KClinicalECPs Share Real-World Experience with DOT Spectacle Lenses
sponsored content June 1, 2022 One of few spectacle lenses available to slow the progression of myopia, SightGlass Vision’s novel Diffusion Optics...
-
3.6KClinicalExperiencing SightGlass Vision’s Spectacle Lenses
December 15, 2021 By Joe Rappon, OD, MS, FAAO, and Kylvin Ho, OD, FIAOMC As children continue to develop myopia at earlier...
-
2.2KLatest Myopia NewsCooperVision Announces Results from Two-Year SightGlass Clinical Trial
October 7, 2021 SAN RAMON, Calif. — CooperVision announced the results from its two-year clinical trial on the SightGlass Diffusion Optics Technology§...
-
1.8KLatest Myopia NewsCooperVision to Present Myopia Management Research at BCLA Conference
June 8, 2021 SAN RAMON, Calif. — CooperVision is slated to present research findings from more than 20 investigations at the upcoming...
-
1.9KLatest Myopia NewsCooperVision’s DreamLite OrthoK Lenses Receive European Approval
May 26, 2021 SAN RAMON, Calif. — CooperVision announced that its DreamLite orthokeratology lenses have officially received approval from the European market...
-
4.5KIn The PipelineCooperVision and EssilorLuxottica Partner to Commercialize SightGlass Myopia Management Lens
February 3, 2021 SAN RAMON, Calif. and CHARENTON-LE-PONT, France – CooperCompanies and EssilorLuxottica entered a joint venture agreement to accelerate commercialization of...